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Background: For each hour of delay from fist medical contact until reperfusion in ST-elevation myocardial
infarction (STEMI) there is a 10% increase in risk of death and heart failure. The aim of this review is to describe the
impact of the direct admission of patients with STEMI to a Catheterisation laboratory (cath lab) as compared with
transport to the emergency department (ED) with regard to delays and outcome.
Methods: Databases were searched for from April-June 2012 and updated January 2014: 1) Pubmed; 2) Embase;
3) Cochrane Library; 4) ProQuest Nursing and 5) Allied Health Sources. The search was restricted to studies in
English, Swedish, Danish and Norwegian languages.
The intervention was a protocol-based clinical pre-hospital pathway and main outcome measurements were the
delay to balloon inflation and hospital mortality.
Results: Median delay from door to balloon was significantly shorter in the intervention group in all 5 studies
reported. Difference in median delay varied between 16 minutes and 47 minutes.
In all 7 included studies the time from symptom onset or first medical contact to balloon time was significantly
shorter in the intervention group. The difference in median delay varied between 15 minutes and 1 hour and
35 minutes. Only two studies described hospital mortality. When combined the risk of death was reduced by 37%.
Conclusion: An overview of available studies of the impact of a protocol-based pre-hospital clinical pathway with
direct admission to a cath lab as compared with the standard transport to the ED in ST-elevation AMI suggests the
following. The delay to the start of revascularisation will be reduced. The clinical benefit is not clearly evidence
based. However, the documented association between system delay and outcome defends the use of the pathway.
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During the last few decades, the treatment of patients
with a presumed acute coronary syndrome (ACS) has
focused on the concept of “time is muscle”. This concept
has become particularly relevant with regard to patients
with ST-segment-elevation myocardial infarction (STEMI)
and reperfusion therapy [1,2].
It was recognised at an early stage that the pre-hospital
initiation of therapy with thrombolysis was valuable with
regard to reperfusion [3]. However, nowadays, a large
number of patients with STEMI are offered reperfusion
therapy with early angioplasty [1].
One way to speed up the process was to admit the
patients directly to a coronary care unit (CCU) which, at
a time of high thrombolysis use, clearly shortened the
door-to-needle time in individual cases. Since the start
of these individual experiences, a number of observational
studies have attempted to explore the effect, on patients
with STEMI, of direct admission to a catheterisation la-
boratory (cath lab) or CCU as compared with the trad-
itional transport to the emergency department (ED). In
these studies, the aim has been to address the effect on
delay and possible effects on patient outcome. To our
knowledge, there is no previous systematic review which
has evaluated the effect of direct admission to a cath lab.
Since clinical pathways of all kinds are resource consum-
ing in relation to the pre-hospital organisation, we believe
that patient benefits must be thoroughly evaluated in
clinical pathways of all kinds.
The primary aim of this survey was to summarise the
present knowledge based on the available literature on
the impact of direct admission to a cath lab as compared
with transport to the ED with regard to delays and out-
come among patients with STEMI.
Method
We have searched for randomised controlled trials (RCT)
that compared the pre-hospital pathway with standard
care. We have also included studies with weaker designs,
such as prospective and retro-perspective observational
studies, before and after studies and studies with a time
series design. The plan for the studies that are included
was to have two groups so that a comparison could
be made.
As a quality assessment tool, the Sign 50 checklist [4]
was used. This checklist is considered to be a satisfactory
tool for assessing study characteristics [5]. To be included
in this review, the studies had to be rated as ++ or +. A ++
rating meant that all or the majority of the criteria for
quality were fulfilled, while a + rating meant that some of
the important criteria were fulfilled. Examples of criteria
that were required are; the cases and controls are taken
from comparable populations; the same exclusion criteria
are used for both cases and controls; comparison is madebetween participants and non-participants to establish
their similarities or differences.
The first screening of titles and abstracts was made by
one of the authors (JH). Abstracts which were of interest
in the first screening were retrieved in full text copies.
Two authors (JH and MH) independently examined the
full text articles guided by the inclusion and exclusion
criteria. Articles which passed the second step were
examined a last time and data were extracted to a data
abstraction form designed for the study.
The inclusion criteria were as follows
a) ST-elevation AMI
b) A protocol-based clinical pre-hospital pathway
meant that patients were identified in the pre-
hospital field and were transported directly to a cath
lab (primary analyses) or to a CCU or intensive
coronary unit (ICU) (secondary analyses).
c) In all the analyses, it should be possible to compare
patients using a protocol-based pre-hospital clinical
pathway with patients who were transported by the
emergency medical service (EMS) to the ED.
Exclusion criteria
Table 1 shows examples of studies [6-19] which, for vari-
ous reasons, had exclusion criteria. The most common
reasons for exclusions were a study design where the
study did not compare direct cath-lab admission with ED
admission, in-hospital pathways and studies in which the
pathway group received thrombolysis instead of PCI.
Outcomes and their definitions
Door-to-balloon time: the time when the patient arrived
at hospital until the time when the balloon was inflated.
The time from symptom onset or first medical contact
to balloon time: the time when reported symptoms
started or when the EMS was called upon until balloon
inflation.




Searches were made in the following databases in
June 2012: PubMed, Embase, the Cochrane Library
and ProQuest Nursing & Allied Health Sources. The
searches were updated in January 2014, and then ProQuest
NAHS was exchanged for CINAHL. The searches were
restricted to studies in English, Swedish, Danish and
Norwegian languages. The following words were used,
with truncation and subject headings adapted to each
database: (Emergency department bypass OR Fast track
OR Clinical Path OR Direct admission OR admitted direct
Table 1 Characteristics of excluded studies after abstract reading
Study Reason for exclusion
Burns et al. 1989 [6] Prehospital pathway where the patients received thrombolysis
Pell et al. 1992 [7] The study evaluated an in-hospital triage system
Davis et al. 1996 [8] A comparison between patients and physicians acceptance of risk
Millar-Craig et al. 1997 [9] Prehospital pathway where the patients received thrombolysis
Prasad et al. 1997 [10] Prehospital pathway where the patients received thrombolysis
Thomas et al. 1997 [11] Prehospital pathway where the patients received thrombolysis
Sandler 1998 [12] Prehospital pathway where the patients received thrombolysis
Villiers et al. 2007 [13] No control group
Ostrzycki et al. 2008 [14] The aim was to investigate time delay in treatment of STEMI patients in four different groups
Zhang et al. 2009 [15] The study evaluated the effect of in-hospital triage
Cheung et al. 2010 [16] The study evaluated the effect of in-hospital triage
Sorensen et al 2011 [17] The aim of the study was to bypass the local hospital and transfer patients direct to PCI center
Abrahamyan et al.2012 [18] The study evaluated the effect of in-hospital triage
Alexandrescu et al. 2012 [19] The study investigated the impact of inter-hospital transfer
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(Myocardial Infarction OR Acute Coronary Syndrome OR
heart infarction OR heart attack OR cardiac infarction).
At a later stage the words STEMI OR ST-elevated myo-
cardial infarction were added to the search, with no new
relevant studies found. Full search strategies for all the
databases are available upon request. In addition to the
database searches we also scanned the reference lists of
the included studies.
Data synthesis
To estimate the average effect across the included stud-
ies, mean effects were calculated. For the dichotomous
data, risk ratios with 95% confidence intervals were used.
As we estimated that there was a possibility of variation
in the true effect across the studies, we decided to use
the “random effect” model [20]. Heterogeneity between
the studies was tested by the standard chi-square test.
For the continuous variables, it was not possible to per-
form a meta-analysis as all the included studies were
presented as median and inter-quartile range. The con-
tinuous data are presented in narrative and tabular form.
A significant effect of the pathway was defined by a P
value less than 0.05. Analyses were performed using
Review Manager (RevMan) [computer program], Version




The search of the databases identified 2007unique cita-
tions (Figure 1). Of them, 1975 were excluded after the
initial screening of titles and abstracts. Eight studies[21-28] met all the inclusion criteria for the primary
analysis (Table 2). No included study had a randomised
controlled design (RCT). The interventions in all the in-
cluded studies were pre-hospital direct admission to a
cath lab compared with the group which was admitted
to the ED by the EMS and, after assessment by ED doc-
tors, was transferred to a cath lab or CCU.
Two studies were included in the secondary analysis
[29,30], where the pathway group was admitted to a CCU.
Primary analyses
Door-to-balloon time
In five of the included studies [21-25], the door-to-
balloon time was reported. The median delay was signifi-
cantly shorter in the intervention group in all five studies.
The difference in median delay varied between 16 minutes
and 47 minutes. Only in one [21] of the five studies was
the difference below 25 minutes (Table 3).
Onset of symptoms or first medical contact to balloon time
In all seven included studies [21-23,25-28], the time from
symptom onset or first medical contact to balloon time
was significantly shorter in the intervention group. The
difference in median delay varied between 15 minutes
and one hour and 35 minutes. Only in three [25,27,28] of
the seven studies was the difference in median delay
lower than 25 minutes (Table 4).
Hospital mortality
Only two studies [21,27] describe hospital mortality.
When combined, the risk of death was reduced by 37%
(Additional file 1).
Figure 1 Flow diagram of included and excluded studies.
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Door-to-balloon time
In two studies [29,30], the median delay was significantly
shorter in the intervention group (direct admission to CCU
or ICU), with a shortening of the median delay of 24 min
(p = <0.01) [29] and 34 min (p = <0.002) [30] respectively.
Discussion
This study, which is based on a systematic review of the
available literature, suggests that a protocol-based pre-
hospital clinical pathway with direct admission to a cath
lab, thereby bypassing the ED, shortens delay to revascu-
larisation and thereby improves outcome in STEMI.
It is important to remember that systematic reviews
including non-randomised trials can be biased in terms of
both under and over-estimates of treatment effects. The
largest bias in non-randomised trials is selection bias [31].
It has been proposed that the most adequate estimate
of delay to revascularisation in AMI is the delay from
calling for the EMS until the start of treatment. This is
called system delay [32].
We found that “door to balloon” and symptom or first
medical contact to balloon was reduced by a time that
varied from about 15 minutes to about one and a half
hours. An overall mean reduction of about 30-40 minutes
is therefore probably a realistic assumption.What survival benefit is to be expected from such a
relatively modest reduction in delay to revascularisation?
The association between system delay and mortality, as
well as the development of heart failure, was most
clearly addressed by Therkelsen et al. [32]. They showed
that, when adjusting for a variety of confounders, for
each hour of increase in system delay, the risk of death
and the risk of complications, defined as heart failure,
increased by 10% during a three-year follow-up [33].
Our results, suggesting that the introduction of a
protocol-based pre-hospital clinical pathway could be as-
sociated with a reduction in hospital mortality of about
30-40%, are more optimistic and deserve consideration.
As neither of the two studies referred to was a rando-
mised clinical trial, the risk of selection bias is obvious.
1) The patient perspective: in all probability,
health-care providers (HCP) tended to admit
younger patients and patients with less comorbidity
directly to a cath lab as compared with those who
were transported to the ED. Most probably, patients
with the most marked ST elevations were more
frequently admitted directly to a cath lab.
2) The time perspective: in all probability, during the
time, at weekends and during holiday months, the
facilities for direct admission were inferior.
Table 2 Characteristics of included studies
Study Design Duration Diagnostic criteria Intervention Number of participants Outcomes included in review
Carstensen et al. 2007 [21] Prospective
observational study
17 months ST elevation>= 1 mm in >=2
contiguous leads or suspected
new LBBB.
Direct admission to catheter lab. Intervention: N=108 - Symptom onset to balloon
time
Control: N=193
- Door to balloon time
- Hospital mortality
Dorsch et al. 2008 [22] Prospective
observational study
14 months Non traumatic chest pain within
last 12 hours. ST elevation in 2
adjacent leads (>1 m V in leads
I-III, aVL, and aVF, and >2 mV
in V1-V6
Direct admission to catheter lab. Intervention: N=172 - Door to balloon time
Control: N=215 - Call to balloon time
- 30 days mortality
Bång et al. 2008 [23] Prospective
observational study
66.5 months St elevation >= 1 mm in ECG
leads I, II, III, AVF, V5 and V6
or >= 2mm in leads V1, V2,
V3 and V4.
Direct admission to ICCU or
catheter lab. The review used
the catheter lab groups data




- From onset of symptoms to
balloon time
Symptoms - balloon time:
Intervention N=115
control N=66
Grosgurin et al. 2010 [24] Before and after 24 months St elevation >=1 mm in 2 or more
contiguous limb leads or ST
elevation >= 2 mm in 2 or more
contiguous precordial leads,
or new LBBB
Direct admission to catheter lab. Intervention: N=119 - Door to balloon time
Control: N=77
Majumder et al. 2011 [25] Retrospective
observational study
31 months Suspicion of STEMI not specified Direct admission to catheter lab. Intervention: N=200 - Door to balloon time
Control: N=161 - Call to balloon time
Cheskes et al. 2011 [26] Before and after 24 months ST elevation >1mm in at least 2
contiguous limb leads or 2 mm in
at least 2 contiguous precordial
leads or LBBB
Direct admission to catheter lab. Intervention N=80
Control N=95
- EMS contact to balloon time
Bagai et al. 2013a [27] Retrospective
observational study
42 months ST segment elevation >=1 mm
in >= 2 contiguous ECG leads
or LBBB or isolated posterior
infarction
Direct admission to catheter lab. Intervention N=1316
and control N=11265
- First medical contact to
balloon time
- Hospital mortality
Bagai et al. 2013b [28] Retrospective
observational study
18 months ST segment elevation >=1 mm
in >= 2 contiguous ECG leads
or LBBB or isolated posterior
infarction
Direct admission to catheter lab. Intervention N=286
and control N=1401
- First medical contact to balloon
time
In the included studies “door to balloon time” is defined as the time from first hospital door to balloon inflated. In this review “symptoms onset to balloon time” is equated to “first medical contact to balloon time”,
“call to balloon time” and “EMS contact to balloon time”.









































Table 3 Direct admission to catheter laboratory vs ED admission
Study ID Number of participants Time; pathway group (minutes) Time; control group (minutes) P value
Carstensen et al. 2007 [21] P N=108, MD=34 (IQR 27-48) MD=50 (IQR 34-85) P<0.001
C N=193
Bång et al. 2008 [23] P N=115, MD=72 (IQR NR) MD=97 (IQR NR) P<0.001
C N=66
Dorsch et al. 2008 [22] P N=172 MD=58 (IQR NR) MD=105 (IQR NR) P<0.001
C N=215
Grosgurin et al. 2010 [24] P N=119 MD=71 (IQR 46-103) MD=109 (IQR 74,5-149,5) P<0.001
C N=77








Door to balloon time.
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diagnosis, greater use of aspirin and a more active ap-
proach to pain relief in the pre-hospital setting might
be associated with direct admission to a cath lab.
4) The in-hospital treatment perspective: patients who
were directly admitted to a cath lab most probably
received anti-ischemic and anti-thrombotic
medication more rapidly than those who were
admitted to an ED.ble 4 Direct admission to catheter laboratory vs ED admiss
udy ID Number of participants Time; pathw
rstensen et al. 2007 [21] P N=108, MD=154 (IQ
C N=193
ng et al. 2008 [23] P N=115, MD=184
C N=66 (IQR NR)
orsch et al. 2008 [22] P N=172 MD=105
C N=215 (IQR NR)
ajumder et al. 2011 [25] P N=200 MD=106 (IQ
C N=161
eskes et al. 2011 [26] P N=80 MD=70 (IQR
C N=95
gai et al. 2013a [27] P N=1316 MD=68 (IQR
C N=11265








mptom onset to balloon time.The implications of these limitations are that the
interpretation of data on clinical benefit must be careful
and, without any randomised study, there is no clear
evidence.
In the secondary analyses, we evaluated the impact of
direct admission to an ICU/CCU. This was also associated
with a significant reduction in door-to-balloon time. With
the introduction of a pathway like this, patients can be
transferred directly from a CCU to a cath lab.ion
ay group (minutes) Time; control group (minutes) P value





R 91-132) MD=130 (IQR 103-164) p<0.005
24) MD=107 (IQR 30) P<0.001
54-85) MD=88 (IQR 73-106) P<0.001
59-93) MD=90 (IQR 76-109) P<0.001
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A protocol-based pre-hospital clinical pathway in ST-
elevation myocardial infarction with direct admission
to a cath lab can be expected to reduce the delay to
revascularisation by about 30-40 minutes. This can be
expected to reduce mortality. The extent of this mor-
tality reduction is probably over-emphasised in this
meta-analysis, due to selection bias. Our analysis sug-
gests a reduction in hospital mortality in the range of
30-40%. Due to the relatively small number of cases,
the confidence limits were wide. When relating our findings
on door-to-balloon time to possible clinical achievements,
it might be realistic to assume a less marked mortality
reduction.
From an ethical perspective, it appears questionable
that any RCT comparing direct admission with transport
to the ED in ST-elevation AMI will ever be performed.
Our interpretation is that direct admission to a cath lab
should be recommended in ST-elevation AMI, despite
the lack of evidence in terms of clinical benefit.
Conclusion
The present systematic review of available studies of the
impact of a protocol-based pre-hospital clinical pathway
with direct admission to a cath lab as compared with the
standard transport to the ED in ST-elevation AMI sug-
gests the following. The delay to the start of revasculari-
sation will be reduced. The clinical benefit is not clearly
evidence based. However, the documented association
between system delay and outcome defends the use of
the pathway.
Additional file
Additional file 1: Direct admission to catheter laboratory vs ED
admission.
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